Inoviq Ltd BDLSF
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 140.78M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.07
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers. The Group operates predominantly in one business segment, the research and development of cancer diagnostics, and two geographical segments, Victoria, Australia, and the United States of America, with the majority of revenue coming from Australia.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 85
- Website
- http://www.inoviq.com
Valuation
|
Metric
|
BDLSF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.02 |
Price/Sales | 2.07 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BDLSF
|
|---|---|
Quick Ratio | 7.54 |
Current Ratio | 7.56 |
Interest Coverage | — |
Quick Ratio
BDLSF
Profitability
|
Metric
|
BDLSF
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
BDLSF
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Kbkwklflz | Cmdd | $184B | |||
| Danaher Corp
DHR
| Drcqsvybn | Vtnkv | $127B | |||
| IDEXX Laboratories Inc
IDXX
| Vrwgyfddsd | Rlsh | $44B | |||
| Agilent Technologies Inc
A
| Lhsybjsvg | Svz | $37B | |||
| Waters Corp
WAT
| Drhrfbjf | Grwmg | $35B | |||
| IQVIA Holdings Inc
IQV
| Vndzdgqc | Kvnqjk | $30B | |||
| Illumina Inc
ILMN
| Yrsnbggm | Dkpblnc | $24B | |||
| Mettler-Toledo International Inc
MTD
| Cvcqzgctj | Ydknxht | $23B | |||
| Quest Diagnostics Inc
DGX
| Dyvmqpyq | Blcqxb | $22B | |||
| Labcorp Holdings Inc
LH
| Wpxxmxkxk | Msdmfz | $22B |
United States